Your browser doesn't support javascript.
loading
Prospective Phase II Trial of Montelukast to Treat Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation and Investigation into Bronchiolitis Obliterans Syndrome Pathogenesis.
Williams, Kirsten M; Pavletic, Steven Z; Lee, Stephanie J; Martin, Paul J; Farthing, Don E; Hakim, Frances T; Rose, Jeremy; Manning-Geist, Beryl L; Gea-Banacloche, Juan C; Comis, Leora E; Cowen, Edward W; Justus, David G; Baird, Kristin; Cheng, Guang-Shing; Avila, Daniele; Steinberg, Seth M; Mitchell, Sandra A; Gress, Ronald E.
Afiliação
  • Williams KM; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia. Electronic address: kwill99@emory.edu.
  • Pavletic SZ; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Lee SJ; Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Martin PJ; Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Farthing DE; Experimental Transplantation and Immunotherapy Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Hakim FT; Experimental Transplantation and Immunotherapy Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Rose J; Experimental Transplantation and Immunotherapy Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Manning-Geist BL; Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Gea-Banacloche JC; Division of Clinical Research, National Institute of Allergy and Immunology, National Institutes of Health, Bethesda, Maryland.
  • Comis LE; Rehabilitation Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland.
  • Cowen EW; Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland.
  • Justus DG; Department of Laboratory Medicine, Boston Children's Hospital, Boston, Massachusetts.
  • Baird K; Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Cheng GS; Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Medicine, University of Washington, Seattle, Washington.
  • Avila D; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Steinberg SM; Biostatistics and Data Management Section, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Mitchell SA; Outcomes Research Branch, Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Gress RE; Experimental Transplantation and Immunotherapy Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Transplant Cell Ther ; 28(5): 264.e1-264.e9, 2022 05.
Article em En | MEDLINE | ID: mdl-35114411

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bronquiolite Obliterante / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bronquiolite Obliterante / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article